These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 26647829)
1. MicroRNA‑145 inhibits the malignant phenotypes of gastric carcinoma cells via downregulation of fascin 1 expression. Xue M; Zhao L; Yang F; Li Z; Li G Mol Med Rep; 2016 Jan; 13(1):1033-9. PubMed ID: 26647829 [TBL] [Abstract][Full Text] [Related]
2. MicroRNA-133a inhibits proliferation and invasion, and induces apoptosis in gastric carcinoma cells via targeting fascin actin-bundling protein 1. Lai C; Chen Z; Li R Mol Med Rep; 2015 Jul; 12(1):1473-8. PubMed ID: 25815687 [TBL] [Abstract][Full Text] [Related]
3. MicroRNA-145 inhibits migration and invasion via inhibition of fascin 1 protein expression in non-small-cell lung cancer cells. Zhang Y; Yang X; Wu H; Zhou W; Liu Z Mol Med Rep; 2015 Oct; 12(4):6193-8. PubMed ID: 26238532 [TBL] [Abstract][Full Text] [Related]
4. MicroRNA-145 and MicroRNA-133a Inhibited Proliferation, Migration, and Invasion, While Promoted Apoptosis in Hepatocellular Carcinoma Cells Via Targeting FSCN1. Wang G; Zhu S; Gu Y; Chen Q; Liu X; Fu H Dig Dis Sci; 2015 Oct; 60(10):3044-52. PubMed ID: 26173501 [TBL] [Abstract][Full Text] [Related]
5. miR-200b inhibits migration and invasion in non-small cell lung cancer cells via targeting FSCN1. Xiao P; Liu W; Zhou H Mol Med Rep; 2016 Aug; 14(2):1835-40. PubMed ID: 27356635 [TBL] [Abstract][Full Text] [Related]
6. The role of microRNA-133b and its target gene FSCN1 in gastric cancer. Guo L; Bai H; Zou D; Hong T; Liu J; Huang J; He P; Zhou Q; He J J Exp Clin Cancer Res; 2014 Nov; 33(1):99. PubMed ID: 25433493 [TBL] [Abstract][Full Text] [Related]
7. Reverse Correlation between MicroRNA-145 and FSCN1 Affecting Gastric Cancer Migration and Invasion. Chen JJ; Cai WY; Liu XW; Luo QC; Chen G; Huang WF; Li N; Cai JC PLoS One; 2015; 10(5):e0126890. PubMed ID: 26010149 [TBL] [Abstract][Full Text] [Related]
8. MicroRNA‑145‑5p suppresses fascin to inhibit the invasion and migration of cervical carcinoma cells. He S; Yu G; Peng K; Liu S Mol Med Rep; 2020 Dec; 22(6):5282-5292. PubMed ID: 33174029 [TBL] [Abstract][Full Text] [Related]
9. Down-regulation of miR-326 is associated with poor prognosis and promotes growth and metastasis by targeting FSCN1 in gastric cancer. Li Y; Gao Y; Xu Y; Ma H; Yang M Growth Factors; 2015; 33(4):267-74. PubMed ID: 26359764 [TBL] [Abstract][Full Text] [Related]
10. MiR-24 functions as a tumor suppressor in nasopharyngeal carcinoma through targeting FSCN1. Li YQ; Lu JH; Bao XM; Wang XF; Wu JH; Hong WQ J Exp Clin Cancer Res; 2015 Oct; 34():130. PubMed ID: 26503504 [TBL] [Abstract][Full Text] [Related]
11. Promoter Methylation-Regulated miR-145-5p Inhibits Laryngeal Squamous Cell Carcinoma Progression by Targeting FSCN1. Gao W; Zhang C; Li W; Li H; Sang J; Zhao Q; Bo Y; Luo H; Zheng X; Lu Y; Shi Y; Yang D; Zhang R; Li Z; Cui J; Zhang Y; Niu M; Li J; Wu Z; Guo H; Xiang C; Wang J; Hou J; Zhang L; Thorne RF; Cui Y; Wu Y; Wen S; Wang B Mol Ther; 2019 Feb; 27(2):365-379. PubMed ID: 30341010 [TBL] [Abstract][Full Text] [Related]
12. miR-145, miR-133a and miR-133b: Tumor-suppressive miRNAs target FSCN1 in esophageal squamous cell carcinoma. Kano M; Seki N; Kikkawa N; Fujimura L; Hoshino I; Akutsu Y; Chiyomaru T; Enokida H; Nakagawa M; Matsubara H Int J Cancer; 2010 Dec; 127(12):2804-14. PubMed ID: 21351259 [TBL] [Abstract][Full Text] [Related]
13. Effect of miR‑145 on gastric cancer cells. Wang J; Sun Z; Yan S; Gao F Mol Med Rep; 2019 May; 19(5):3403-3410. PubMed ID: 30864704 [TBL] [Abstract][Full Text] [Related]
14. Down-regulation of long noncoding RNA PVT1 inhibits esophageal carcinoma cell migration and invasion and promotes cell apoptosis via microRNA-145-mediated inhibition of FSCN1. Shen SN; Li K; Liu Y; Yang CL; He CY; Wang HR Mol Oncol; 2019 Dec; 13(12):2554-2573. PubMed ID: 31369196 [TBL] [Abstract][Full Text] [Related]
15. MicroRNA‑663 suppresses the proliferation and invasion of colorectal cancer cells by directly targeting FSCN1. Yu S; Xie H; Zhang J; Wang D; Song Y; Zhang S; Zheng S; Wang J Mol Med Rep; 2017 Dec; 16(6):9707-9714. PubMed ID: 29039557 [TBL] [Abstract][Full Text] [Related]
16. miR-145 overexpression suppresses the migration and invasion of metastatic melanoma cells. Dynoodt P; Speeckaert R; De Wever O; Chevolet I; Brochez L; Lambert J; Van Gele M Int J Oncol; 2013 Apr; 42(4):1443-51. PubMed ID: 23404256 [TBL] [Abstract][Full Text] [Related]
17. miR-145 and miR-133a function as tumour suppressors and directly regulate FSCN1 expression in bladder cancer. Chiyomaru T; Enokida H; Tatarano S; Kawahara K; Uchida Y; Nishiyama K; Fujimura L; Kikkawa N; Seki N; Nakagawa M Br J Cancer; 2010 Mar; 102(5):883-91. PubMed ID: 20160723 [TBL] [Abstract][Full Text] [Related]
18. miR-539 inhibits FSCN1 expression and suppresses hepatocellular carcinoma migration and invasion. Liu Y; Hong W; Zhou C; Jiang Z; Wang G; Wei G; Li X Oncol Rep; 2017 May; 37(5):2593-2602. PubMed ID: 28393215 [TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA PCAT-1 contributes to tumorigenesis by regulating FSCN1 via miR-145-5p in prostate cancer. Xu W; Chang J; Du X; Hou J Biomed Pharmacother; 2017 Nov; 95():1112-1118. PubMed ID: 28922730 [TBL] [Abstract][Full Text] [Related]
20. Restoration of miR-145 expression suppresses cell proliferation, migration and invasion in prostate cancer by targeting FSCN1. Fuse M; Nohata N; Kojima S; Sakamoto S; Chiyomaru T; Kawakami K; Enokida H; Nakagawa M; Naya Y; Ichikawa T; Seki N Int J Oncol; 2011 Apr; 38(4):1093-101. PubMed ID: 21258769 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]